retatrutide phase 2 type 2 diabetes trial Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized 2a retatrutide nash trial Phase 2
Pay in 4 interest-free payments of $6.52 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1























